The first West Pharmaceutical Services trade was made in Q3 2020.
Since then Ray Dalio bought shares six more times and sold shares on nine occasions. The investor completely sold their stake between Q4 2022 and Q2 2024.
Avg closing price
Price range
Sold -1.29 Thousand shares
Q2 2024
Avg closing price
$353.40
Price range
$314.68
-
$395.94
Sold 70.6% shares (-3.1 Thousand shares)
Q1 2024
Avg closing price
$369.91
Price range
$338.27
-
$413.00
Sold 5.6% shares (-262 shares)
Q4 2023
Avg closing price
$353.90
Price range
$318.29
-
$392.21
Sold 5.7% shares (-280 shares)
Q3 2023
Avg closing price
$386.88
Price range
$354.90
-
$412.41
Sold 0.6% shares (-30 shares)
Q2 2023
Avg closing price
$357.24
Price range
$334.63
-
$382.47
Sold 59.4% shares (-7.25 Thousand shares)
Q1 2023
Avg closing price
$292.19
Price range
$232.50
-
$346.47
Sold 71.0% shares (-29.9 Thousand shares)
Q4 2022
Avg closing price
$236.96
Price range
$209.34
-
$261.61
Increased shares by 81.7% (+18.9 Thousand shares)
Q3 2022
Avg closing price
$304.64
Price range
$246.08
-
$343.65
Increased shares by 112.6% (+12.3 Thousand shares)
Q2 2022
Avg closing price
$325.39
Price range
$280.61
-
$420.45
Increased shares by 30.2% (+2.53 Thousand shares)
Q1 2022
Avg closing price
$391.48
Price range
$357.49
-
$445.92
Sold 90.1% shares (-75.7 Thousand shares)
Q4 2021
Avg closing price
$430.44
Price range
$402.25
-
$471.34
Sold 4.0% shares (-3.5 Thousand shares)
Q3 2021
Avg closing price
$421.55
Price range
$363.01
-
$468.47
Increased shares by 80.6% (+39.1 Thousand shares)
Q2 2021
Avg closing price
$330.40
Price range
$284.77
-
$363.20
Increased shares by 14.5% (+6.13 Thousand shares)
Q1 2021
Avg closing price
$286.20
Price range
$257.29
-
$307.53
Increased shares by 140.1% (+24.7 Thousand shares)
Q4 2020